OnKure Therapeutics, Inc.
OKUR
$2.82
-$0.015-0.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.75% | -12.73% | -3.20% | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -22.04% | -32.60% | 49.22% | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -13.87% | -13.12% | 4.79% | ||
|
|
|||||
| Total Current Assets | -13.87% | -13.12% | 4.79% | ||
| Net Property, Plant & Equipment | -12.43% | -10.81% | -7.92% | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 6.42% | 0.00% | -3.92% | ||
| Total Assets | -13.83% | -13.08% | 3.86% | ||
|
|
|||||
| Total Accounts Payable | 1.58% | -21.02% | 128.02% | ||
| Total Accrued Expenses | -20.95% | -16.10% | 162.65% | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 1.83% | 1.87% | 1.89% | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | -13.52% | -16.57% | 133.90% | ||
|
|
|||||
| Total Current Liabilities | -13.52% | -16.57% | 133.90% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -34.72% | -25.50% | -13.35% | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 0.00% | -- | -- | ||
| Total Liabilities | -14.40% | -16.65% | 222.40% | ||
|
|
|||||
| Common Stock & APIC | 1.11% | 1.06% | 559.20% | ||
| Retained Earnings | -9.02% | -10.29% | -12.67% | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -13.77% | -12.69% | -11.07% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | 0.00% | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | 0.00% | ||
|
|
|||||
| Total Common Equity | -13.77% | -12.69% | -11.07% | ||
| Total Preferred Equity | -- | -- | 0.00% | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -13.77% | -12.69% | -66.34% | ||
|
|
|||||